Managed by Brandon Capital, Brandon BioCatalyst supports the development and commercialisation of early-stage biomedical discoveries originating from Australian and New Zealand member research organisations, providing both capital and expertise to guide the successful development of new therapies.
Brandon BioCatalyst is a unique collaboration of investors, government and over 50 of Australia and New Zealand’s leading medical research institutes united by a single purpose: progressing the next generation of medical therapies and technology which improve health and save lives.
